Cost-efficiency analysis of conversion to biosimilar filgrastim for supportive cancer care and resultant expanded access analysis to supportive care and early-stage HER2+ breast cancer treatment in Saudi Arabia: simulation study
- Resource Type
- Source
- Journal of Medical Economics. 26:394-402
- Subject
Health Policy - Language
- ISSN
- 1941-837X
1369-6998